Assured Investment Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q2 | – | Sell |
-56,568
| Closed | -$4.44M | – | 468 |
|
2019
Q1 | $4.44M | Sell |
56,568
-20,121
| -26% | -$1.58M | 0.05% | 157 |
|
2018
Q4 | $6.49M | Buy |
76,689
+62,443
| +438% | +$5.29M | 0.18% | 121 |
|
2018
Q3 | $2.44M | Sell |
14,246
-14,021
| -50% | -$2.4M | 0.04% | 366 |
|
2018
Q2 | $3.65M | Buy |
28,267
+23,043
| +441% | +$2.98M | 0.07% | 278 |
|
2018
Q1 | $538K | Buy |
+5,224
| New | +$538K | 0.01% | 718 |
|
2017
Q2 | – | Sell |
-4,400
| Closed | -$291K | – | 624 |
|
2017
Q1 | $291K | Buy |
+4,400
| New | +$291K | 0.01% | 452 |
|